Supplements

Advances in Hematology and Oncology

Publish date: May 20, 2021

 

Federal Practitioner Supplement: Advances in Hematology and Oncology

  • Impact of an Oral Antineoplastic Renewal Clinic
  • Implementing Comprehensive Geriatric Assessments for Oncology Patients
  • Radiation Toxicity and Survival in Patients with Presumed Early-Stage NCSLC
  • Screening High-Risk Women Veterans for Breast Cancer
  • Standardizing the Discharge Process for Inpatient Hem/Onc
  • Massive Retroperitoneal Liposarcoma Masquerading as Meralgia Paresthetica
  • Delayed Coronary Vasospasm in Metastatic Gastric Cancer

THIS ISSUE WAS PRODUCED IN COLLABORATION WITH AVAHO

Recommended Reading

Possible obesity effect detected in cancer death rates
AVAHO
Use of Comprehensive Geriatric Assessment in Oncology Patients to Guide Treatment Decisions and Predict Chemotherapy Toxicity
AVAHO
Impact of an Oral Antineoplastic Renewal Clinic on Medication Possession Ratio and Cost-Savings
AVAHO
Factors Associated with Radiation Toxicity and Survival in Patients with Presumed Early-Stage Non-Small Cell Lung Cancer Receiving Empiric Stereotactic Ablative Radiotherapy
AVAHO
Standardization of the Discharge Process for Inpatient Hematology and Oncology Using Plan-Do-Study-Act Methodology Improves Follow-Up and Patient Hand-Off
AVAHO
Delayed Coronary Vasospasm in a Patient with Metastatic Gastric Cancer Receiving FOLFOX Therapy
AVAHO
Esophageal cancer: Preoperative chemoradiotherapy benefit in CROSS persists over 10 years
AVAHO
BERENICE: Further evidence of heart safety of dual HER2 blockade
AVAHO
Telemedicine is popular among Mohs surgeons – for now
AVAHO
FDA approves new treatment option for rare anemia
AVAHO